共 38 条
[1]
Wang HT(2014)Neuroendocrine prostate cancer (nepc) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of nepc and survival from nepc diagnosis-a systematic review and pooled analysis J Clin Oncol 32 3383-3390
[2]
Lapuk AV(2012)From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer J Pathol 227 286-297
[3]
Yao JL(2006)Small cell carcinoma of the prostate: an immunohistochemical study Am J surg pathol 30 705-712
[4]
Kumar A(2016)Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer Nat Med 22 369-378
[5]
Beltran H(2016)Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer Nat Med 22 298-305
[6]
Roudier MP(2004)Metastatic conventional prostatic adenocarcinoma with diffuse chromogranin a and androgen receptor positivity J Clin Pathol 57 321-323
[7]
Wu C(2012)Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer J Pathol 227 53-61
[8]
Beltran H(2011)Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets Cancer Discov 1 487-495
[9]
Lin D(2014)High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development Cancer Res 74 1272-1283
[10]
Tzelepi V(2012)Modeling a lethal prostate cancer variant with small-cell carcinoma features Clin Cancer Res 18 666-677